The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo
1998

Effects of Norethisterone on Endometrial Abnormalities in Post-Menopausal Women on Tamoxifen

Sample size: 463 publication Evidence: moderate

Author Information

Author(s): TJ Powles, T Bourne, S Athanasiou, J Chang, K Grubock, S Ashley, L Oakes, A Tidyl, J Davey, J Viggers, S Humphries, W Collins

Primary Institution: Royal Marsden Hospital

Hypothesis

Does norethisterone help reduce endometrial abnormalities in post-menopausal women taking tamoxifen?

Conclusion

The study found that while norethisterone did not reverse endometrial abnormalities, most women experienced withdrawal bleeding, indicating an oestrogenically primed endometrium.

Supporting Evidence

  • 24% of women on tamoxifen had persistent endometrial thickening compared to 2% on placebo.
  • 15% of women on tamoxifen had cystic changes and 11% had polyps.
  • 96% of women on tamoxifen experienced withdrawal bleeding after norethisterone treatment.

Takeaway

This study looked at women taking tamoxifen and found that many had changes in their uterus, but a medicine called norethisterone didn't fix those changes.

Methodology

The study involved regular transvaginal ultrasound screenings and the administration of norethisterone to women with identified endometrial thickening.

Potential Biases

Potential observer bias in ultrasound assessments and histological evaluations.

Limitations

The study had a small sample size and relied on ultrasound findings without adequate histological confirmation for all participants.

Participant Demographics

Post-menopausal women, median age 57, with a family history of breast cancer.

Statistical Information

P-Value

<0.0005

Statistical Significance

p<0.0005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication